Literature DB >> 20215782

CA-125 monitoring in ovarian cancer: patient survey responses to the results of the MRC/EORTC CA-125 Surveillance Trial.

Maurie Markman, Judith Petersen, Angela Belland, Kenda Burg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20215782     DOI： 10.1159/000292352

Source DB:  PubMed          Journal:  Oncology        ISSN： 0030-2414            Impact factor:   2.935


× No keyword cloud information.
  5 in total

1.  Carbohydrate-antigen-125 levels predict hospital stay duration and adverse events at long-term follow-up in Takotsubo cardiomyopathy.

Authors:  Francesco Santoro; Armando Ferraretti; Francesco Musaico; Luigi Di Martino; Nicola Tarantino; Riccardo Ieva; Matteo Di Biase; Natale Daniele Brunetti
Journal:  Intern Emerg Med       Date:  2016-02-01       Impact factor: 3.397

2.  Ovarian cancer recurrence detection may not require in-person physical examination: an MSK team ovary study.

Authors:  Jacqueline Feinberg; Karen Carthew; Emily Webster; Kaity Chang; Nita McNeil; Dennis S Chi; Kara Long Roche; Ginger Gardner; Oliver Zivanovic; Yukio Sonoda
Journal:  Int J Gynecol Cancer       Date:  2021-12-29       Impact factor: 3.437

3.  Dual use of a single Wilms' tumor 1 immunohistochemistry in evaluation of ovarian tumors: a preliminary study of 20 cases.

Authors:  Yi-Hsuan Hsiao; Sarwat Siddiqui; Yan-Gao Man
Journal:  J Cancer       Date:  2010-07-13       Impact factor: 4.207

4.  The prognostic factor for recurrence in advanced-stage high-grade serous ovarian cancer after complete clinical remission: a nested case-control study.

Authors:  Qiao Wang; Ying Zheng; Ping Wang; Jiawen Zhang; Hui Liu; Qingli Li; Rutie Yin; Ce Bian; Hongling Peng; Zhilan Peng
Journal:  J Ovarian Res       Date:  2021-12-20       Impact factor: 4.234

5.  Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer.

Authors:  Katharine M Esselen; Angel M Cronin; Kristin Bixel; Michael A Bookman; Robert A Burger; David E Cohn; Mihaela Cristea; Jennifer J Griggs; Charles F Levenback; Gina Mantia-Smaldone; Larissa A Meyer; Ursula A Matulonis; Joyce C Niland; Charlotte Sun; David M O'Malley; Alexi A Wright
Journal:  JAMA Oncol       Date:  2016-11-01       Impact factor: 31.777
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.